Collectively, our findings demonstrate that PSMD1 knockdown inhibits HCC proliferation, induces apoptosis, and enhances the therapeutic efficacy of PD-1 blockade, highlighting PSMD1 as a promising target for therapeutic intervention (Fig. 8G). This evidence concerns the gene PSMD1 and hepatocellular carcinoma.